Manufacturers Life Insurance Company, The Poseida Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 25,455 shares of PSTX stock, worth $241,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,455
Previous 27,273
6.67%
Holding current value
$241,822
Previous $78,000
212.82%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PSTX
# of Institutions
119Shares Held
40.7MCall Options Held
135KPut Options Held
439K-
Pentwater Capital Management LP Naples, FL8.63MShares$81.9 Million0.95% of portfolio
-
Nomura Holdings Inc Tokyo, M05.12MShares$48.6 Million0.07% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.83MShares$36.4 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.02MShares$19.2 Million1.2% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...